Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) Return on Sales (2020 - 2025)

Stemtech (STEK) has disclosed Return on Sales for 6 consecutive years, with 0.95% as the latest value for Q3 2025.

  • Quarterly Return on Sales rose 18.0% to 0.95% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.79% through Sep 2025, up 23.0% year-over-year, with the annual reading at 0.75% for FY2024, 36.0% up from the prior year.
  • Return on Sales hit 0.95% in Q3 2025 for Stemtech, down from 0.42% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 16.61% in Q3 2022 to a low of 19.56% in Q2 2022.
  • Historically, Return on Sales has averaged 1.15% across 5 years, with a median of 0.75% in 2021.
  • Biggest YoY gain for Return on Sales was 2246bps in 2022; the steepest drop was -1881bps in 2022.
  • Year by year, Return on Sales stood at 0.65% in 2021, then rose by 22bps to 0.5% in 2022, then plummeted by -173bps to 1.37% in 2023, then skyrocketed by 78bps to 0.3% in 2024, then crashed by -216bps to 0.95% in 2025.
  • Business Quant data shows Return on Sales for STEK at 0.95% in Q3 2025, 0.42% in Q2 2025, and 1.68% in Q1 2025.